| Behavioral phenotyping of mice in pharmacological and toxicological research T Karl, R Pabst, S von Hörsten Experimental and toxicologic pathology 55 (1), 69-83, 2003 | 334 | 2003 |
| Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity D Boey, S Lin, T Karl, P Baldock, N Lee, R Enriquez, M Couzens, K Slack, ... Diabetologia 49 (6), 1360-1370, 2006 | 206 | 2006 |
| A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice LE Long, R Chesworth, XF Huang, IS McGregor, JC Arnold, T Karl International Journal of Neuropsychopharmacology 13 (7), 861-876, 2010 | 205 | 2010 |
| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol AA Boucher, JC Arnold, L Duffy, PR Schofield, J Micheau, T Karl Psychopharmacology 192 (3), 325-336, 2007 | 198 | 2007 |
| Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats C Klein, E Karanges, A Spiro, A Wong, J Spencer, T Huynh, ... Psychopharmacology 218 (2), 443-457, 2011 | 186 | 2011 |
| Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease WS Kim, H Li, K Ruberu, S Chan, DA Elliott, JK Low, D Cheng, T Karl, ... Journal of Neuroscience 33 (10), 4387-4394, 2013 | 185 | 2013 |
| Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia T Karl, L Duffy, A Scimone, RP Harvey, PR Schofield Genes, Brain and Behavior 6 (7), 677-687, 2007 | 185 | 2007 |
| In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease G Watt, T Karl Frontiers in pharmacology 8, 20, 2017 | 155 | 2017 |
| Behavioural profile of a new mouse model for NPY deficiency T Karl, L Duffy, H Herzog European Journal of Neuroscience 28 (1), 173-180, 2008 | 145 | 2008 |
| Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice D Cheng, AS Spiro, AM Jenner, B Garner, T Karl Journal of Alzheimer's disease 42 (4), 1383-1396, 2014 | 142 | 2014 |
| Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆ E9 mice D Cheng, JK Low, W Logge, B Garner, T Karl Psychopharmacology 231 (15), 3009-3017, 2014 | 131 | 2014 |
| Y1 receptors regulate aggressive behavior by modulating serotonin pathways T Karl, S Lin, C Schwarzer, A Sainsbury, M Couzens, W Wittmann, D Boey, ... Proceedings of the National Academy of Sciences 101 (34), 12742-12747, 2004 | 107 | 2004 |
| Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation M van den Buuse, L Wischhof, RX Lee, S Martin, T Karl International Journal of Neuropsychopharmacology 12 (10), 1383-1393, 2009 | 106 | 2009 |
| Cognition in transmembrane domain neuregulin 1 mutant mice L Duffy, E Cappas, D Lai, AA Boucher, T Karl Neuroscience 170 (3), 800-807, 2010 | 105 | 2010 |
| Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety T Karl, THJ Burne, H Herzog Behavioural brain research 167 (1), 87-93, 2006 | 105 | 2006 |
| Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice LE Long, R Chesworth, XF Huang, A Wong, A Spiro, IS McGregor, ... PloS one 7 (4), e34129, 2012 | 98 | 2012 |
| Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4 N Frerker, L Wagner, R Wolf, U Heiser, T Hoffmann, JU Rahfeld, J Schade, ... Peptides 28 (2), 257-268, 2007 | 89 | 2007 |
| Behavioral profiling of NPY in aggression and neuropsychiatric diseases T Karl, H Herzog Peptides 28 (2), 326-333, 2007 | 83 | 2007 |
| Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence LE Long, R Chesworth, XF Huang, IS McGregor, JC Arnold, T Karl International Journal of Neuropsychopharmacology 16 (1), 163-175, 2013 | 80 | 2013 |
| Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differences T Karl, T Hoffmann, R Pabst, S von Hörsten Physiology & behavior 80 (1), 123-134, 2003 | 80 | 2003 |
